Physician

Gregg Anthony Severs, D.O.

According to 2025 Medicare claims, Gregg Severs, D.O. (NPI: 1205964368) practices dermatology in the Scranton--Wilkes-Barre, PA market, with the plurality of this provider's patient population coming from Lackawanna, PA. This provider's primary affiliated billing organization is LACKAWANNA VALLEY DERMATOLOGY ASSOCIATES LIMITED (NPI: 1982791117; TIN: 23-2414001) and primary practice location at 18503-1535.

Severs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 671 traditional Medicare patients, billed 5,932 HCPCS/CPT codes, and received $478,284 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,215 prescription claims across 460 beneficiaries totaling $1,032,131 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 24 records totaling $236. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $329,002 to $1,032,131. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$239K$478K2015 Medicare payment: $194,626 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $187,892 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $180,939 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $185,417 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $155,167 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $114,222 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $125,375 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $225,700 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $196,859 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $478,284 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159494,740$194,626
20168504,081$187,892
20179064,335$180,939
20188683,484$185,417
20197392,840$155,167
20205902,287$114,222
20215772,231$125,375
20226103,161$225,700
20236613,014$196,859
20246715,932$478,284

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$627K$1.3M2015 Drug cost: $329,002 (USD; Tot_Drug_Cst)2016 Drug cost: $411,580 (USD; Tot_Drug_Cst)2017 Drug cost: $374,877 (USD; Tot_Drug_Cst)2018 Drug cost: $544,576 (USD; Tot_Drug_Cst)2019 Drug cost: $573,659 (USD; Tot_Drug_Cst)2020 Drug cost: $586,158 (USD; Tot_Drug_Cst)2021 Drug cost: $488,402 (USD; Tot_Drug_Cst)2022 Drug cost: $933,658 (USD; Tot_Drug_Cst)2023 Drug cost: $1,253,814 (USD; Tot_Drug_Cst)2024 Drug cost: $1,032,131 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015397977$329,002
2016389948$411,580
20173901,045$374,877
20184171,209$544,576
20193851,033$573,659
20204481,270$586,158
20213951,050$488,402
20223741,015$933,658
20233831,078$1,253,814
20244601,215$1,032,131

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths213252$75
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more352469$64
11102Biopsy of related skin growth, first growth140160$58
17000Destruction of precancer skin growth, 1 growth233295$32
17003Destruction of precancer skin growth, 2-14 growths162851$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa131,036$271,718
Dupixent PenDupilumab371,022$146,391
Taltz AutoinjectorIxekizumab13392$98,633
Doxycycline HyclateDoxycycline Hyclate763,059$5,693
TacrolimusTacrolimus25819$3,477

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$236ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gregg Anthony Severs, D.O.?

Tedicare shows public-source Medicare data for Gregg Anthony Severs, D.O. (NPI 1205964368), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregg Anthony Severs, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gregg Anthony Severs, D.O.?

Gregg Anthony Severs, D.O. is linked to LACKAWANNA VALLEY DERMATOLOGY ASSOCIATES LIMITED (billing NPI 1982791117) in the available physician profile data.

Does Gregg Anthony Severs, D.O. have Open Payments data?

Gregg Anthony Severs, D.O. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.